Nateglinide for type 2 diabetes

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2001年 / 43卷 / 1101期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
下载
收藏
页码：29 / 30
页数：2
相关论文
共 50 条
  • [41] Efficacy and safety of nateglinide plus vildagliptin combination therapy compared with switching to vildagliptin in type 2 diabetes patients inadequately controlled with nateglinide
    Kudo-Fujimaki, Kyoko
    Hirose, Takahisa
    Yoshihara, Tomoaki
    Sato, Fumihiko
    Someya, Yuki
    Ohmura, Chie
    Kanazawa, Akio
    Fujitani, Yoshio
    Watada, Hirotaka
    JOURNAL OF DIABETES INVESTIGATION, 2014, 5 (04) : 400 - 409
  • [42] Synergistic effects of nateglinide and meal administration on insulin secretion in patients with type 2 diabetes mellitus
    Keilson, L
    Mather, S
    Walter, YH
    Subramanian, S
    McLeod, JF
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (03): : 1081 - 1086
  • [43] Nateglinide enhances first phase insulin secretion and glucose clearance in type 2 diabetes.
    Kahn, SE
    Montgomery, B
    Ligueros-Saylan, M
    Hsu, C
    Devineni, D
    Mcleod, JF
    Horowitz, AD
    DIABETOLOGIA, 2000, 43 : A187 - A187
  • [44] Efficacy and safety of repaglinide vs nateglinide for treatment of Japanese patients with type 2 diabetes mellitus
    Kawamori, Ryuzo
    Kaku, Kohei
    Hanafusa, Toshiaki
    Kashiwabara, Daisuke
    Kageyama, Shigeru
    Hotta, Nigishi
    JOURNAL OF DIABETES INVESTIGATION, 2012, 3 (03) : 302 - 308
  • [45] Effects of nateglinide in combination with basal insulin glargine with metformin and/or thiazolidinedione in type 2 diabetes patients
    Israel, Marc K.
    Dabrowski, Irena
    Purkayastha, Das
    DIABETES, 2008, 57 : A572 - A572
  • [46] Comparison of the acute effects of nateglinide versus glibenclamide on postprandial metabolic control in type 2 diabetes
    Dimitriadis, G
    Boutati, E
    Lambadiari, V
    Mitrou, P
    Maratou, I
    Samartzis, A
    Raptis, SA
    DIABETES, 2002, 51 : A95 - A95
  • [47] Acute nateglinide administration in subjects with type 2 diabetes: Effects on postprandial metabolism, coagulation, and fibrinolysis
    Tentolouris, N
    Boutati, E
    Karambakalis, N
    Perea, D
    Tselepis, AD
    Tsoukala, C
    Kyriaki, D
    Lourida, E
    Anastasopoulou, I
    Karafoullidou, A
    Raptis, SA
    Katsilambros, N
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2005, 15 (01) : 6 - 12
  • [48] No acute effect of nateglinide on postprandial lipid and lipoprotein responses in subjects at risk for type 2 diabetes
    Johanson, EH
    Jansson, PA
    Gustafson, B
    Sandqvist, M
    Taskinen, MR
    Smith, U
    Axelsen, M
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2005, 21 (04) : 376 - 381
  • [49] Nateglinide increases first phase insulin secretion and enhances glucose clearance in type 2 diabetes
    Kahn, SE
    Montgomery, B
    Howell, WM
    Ligueros-Saylan, M
    Hsu, CH
    Devineni, D
    McLeod, JF
    Horowitz, AD
    DIABETES, 2000, 49 : A113 - A113
  • [50] P34 Effects of nateglinide and metformin on glycated insulin secretion in type 2 diabetes
    Crawford, M. A.
    O'Harte, F. P. M.
    Cuthbertson, J.
    Bell, P. R.
    Flatt, P. R.
    McKillop, A. M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2011, 180 : S496 - S496
12345